Cargando…
Machine-learning-based prediction of the effectiveness of the delivered dose by exhale-gated radiotherapy for locally advanced lung cancer: The additional value of geometric over dosimetric parameters alone
PURPOSE: This study aimed to assess interfraction stability of the delivered dose distribution by exhale-gated volumetric modulated arc therapy (VMAT) or intensity-modulated arc therapy (IMAT) for lung cancer and to determine dominant prognostic dosimetric and geometric factors. METHODS: Clinical ta...
Autores principales: | Guberina, Nika, Pöttgen, Christoph, Santiago, Alina, Levegrün, Sabine, Qamhiyeh, Sima, Ringbaek, Toke Printz, Guberina, Maja, Lübcke, Wolfgang, Indenkämpen, Frank, Stuschke, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880443/ https://www.ncbi.nlm.nih.gov/pubmed/36713497 http://dx.doi.org/10.3389/fonc.2022.870432 |
Ejemplares similares
-
Respiration-controlled radiotherapy in lung cancer: Systematic evaluation of the optimal application practice
por: Guberina, M., et al.
Publicado: (2023) -
Comparison of Online-Onboard Adaptive Intensity-Modulated Radiation Therapy or Volumetric-Modulated Arc Radiotherapy With Image-Guided Radiotherapy for Patients With Gynecologic Tumors in Dependence on Fractionation and the Planning Target Volume Margin
por: Guberina, Maja, et al.
Publicado: (2023) -
Fractionation versus Adaptation for Compensation of Target Volume Changes during Online Adaptive Radiotherapy for Bladder Cancer: Answers from a Prospective Registry
por: Pöttgen, Christoph, et al.
Publicado: (2023) -
Spatial and dosimetric evaluation of residual distortions of prostate and seminal vesicle bed after image‐guided definitive and postoperative radiotherapy of prostate cancer with endorectal balloon
por: Levegrün, Sabine, et al.
Publicado: (2020) -
Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF‐phase I/II trial
por: Nour, Youness, et al.
Publicado: (2021)